October 28, 2019

Ziopharm Oncology and MD Anderson Cancer Enter R&D Agreement

Ziopharm Oncology and MD Anderson Cancer Center entered a research and development agreement for the company's Sleeping Beauty program.
October 1, 2019

Ziopharm Oncology Receives FDA Clearance of Rapid Personalized Manufacture of CD19-specific CAR-T

The company received clearance from the FDA for a Phase 1 clinical trial for patients with relapsed CD19 leukemias and...
June 26, 2019

Ziopharm Oncology Completes Enrollment of Controlled IL-12 plus Opdivo Phase 1 Combination Trial

Ziopharm Oncology (NASDAQ:ZIOP) has announced it has finished enrolling the third cohort of a Phase 1 clinical trial testing Controlled...
June 11, 2019

Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial

Ziopharm Oncology (NASDAQ:ZIOP) has announced that its investigational new drug (IND) application which was submitted by the National Cancer Institute...
December 28, 2018

Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets

Ziopharm Oncology (Nasdaq:ZIOP) today responded to the recent decline in the Company’s stock price, which accelerated greatly on December 26,...
September 23, 2018

5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top

Molecular Templates, Galectin Therapeutic, Chiasma, ZioPharm Oncology and Caladrius Biosciences were last week's top gainers on the NASDAQ Biotechnology Index.